Researchers report encouraging Phase 1 data for glioblastoma treatment
Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92% of evaluable patients treated with INB-200 exceeded a median ...
Jun 5, 2024
0
0